Showing 411-420 of 10581 results for "".
Melanoma Treatment Breakthroughs: Improving Long-Term Survival
https://reachmd.com/programs/medical-industry-feature/melanoma-treatment-breakthroughs-improving-long-term-survival/32930/Explore how early immunotherapy and emerging treatments are reshaping survival rates for patients with melanoma.Legal Issues to Consider When Implementing GLP-1 and Other Weight Loss Drugs into Your Medical Aesthetics Business
https://reachmd.com/topics/practice-development/legal-issues-to-consider-when-implementing-glp-1-and-other-weight-loss-drugs-into-your-medical-aesthetics-business/35424/Legal Issues to Consider When Implementing GLP-1 and Other Weight Loss Drugs into Your Medical Aesthetics BusinessSurgical Procedures for Complex Frontal Sinus Disease
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/surgical-procedures-for-complex-frontal-sinus-disease/5538/Sinusitis can be debilitating. Complex frontal sinus disease may be categorized as infectious, or due to tumors or trauma. When frontal sinus disease is refractory to medical management, what types of surgery should we consider? Dr. James Palmer, associate professor and director of the division of rEvaluating the Global Impact of Surgical Checklists
https://reachmd.com/programs/clinicians-roundtable/evaluating-the-global-impact-of-surgical-checklists/4272/The annual number of surgeries performed worldwide outnumbers even childbirth. What do the latest studies examining surgical checklists tell us about their impact on reducing global morbidity and mortality? Sharing insights on this subject is Dr. Alex Haynes, surgical research fellow at the HarvardAlzheimer's Disease: What Does the Future Hold For Treatment?
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/alzheimers-disease-what-does-the-future-hold-for-treatment/4037/We know genetic mutations can cause Alzheimer's disease, so what possibilities are there for intervention to prevent patients from developing Alzheimer's, thanks to genetic discoveries? What strategies are being used to treat Alzheimer's, and which ones might be applied in the near future? Dr. SamueIncisionless Brain Surgery
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/incisionless-brain-surgery/3873/Minimally-invasive surgery is generally an attractive option, but how reliable and effective is brain surgery performed through the nose? Dr. Jason Newman, assistant professor of otolaryngology - head and neck surgery at the University of Pennsylvania School of Medicine, explores the rapidly evolvinRobotic Surgical Advances for Prostatectomies
https://reachmd.com/programs/clinicians-roundtable/robotic-surgical-advances-for-prostatectomies/3179/Does robotic surgery for radical prostatectomy provide better outcomes? Our guest Dr. Tewari Ash, director of robotic prostatectomy and prostate cancer-urologic oncology outcomes at Brady Urology Institute and associate professor of associate professor of public health and outcomes in the DepartmenAortic Stenosis and Percutaneous AV Replacement
https://reachmd.com/programs/clinicians-roundtable/aortic-stenosis-and-percutaneous-av-replacement/2304/Each year more than 200,000 patients do not receive surgical valve replacement due to excessive risk factors, refusal of surgery and comorbidities. Percutaneous aortic valve replacement, a less invasive option, could provide the life saving alternative treatment your patient needs. Join host Dr. MarAmerican College of Surgeons Agenda 2008
https://reachmd.com/programs/clinicians-roundtable/american-college-of-surgeons-agenda-2008/2227/What are the priorities of the American College of Surgeons in 2008? What are the challenges faced by the surgical specialty and how can they be overcome? In this segment Dr. Thomas Russell, Executive Director of the American College of Surgeons talks with host, Dr. Mark Nolan Hill about the ACSPersonalizing Prostate Cancer Surveillance: Insights from Canary PASS
https://reachmd.com/programs/frontlines-prostate-cancer/personalizing-prostate-cancer-surveillance-insights-from-canary-pass/32224/For patients with early-stage prostate cancer, routine clinical variables like Gleason scores or PSAs have their limits. The Canary Prostate Active Surveillance Study (Canary PASS) is reshaping our management approach through improved risk stratification. Dr. Lisa Newcomb joins us to explain the fin